Dipartimento delle Scienze Biologiche, Facolta di Scienze Biotecnologiche, Universita di Napoli Federico II, via Mezzocannone 16, 80134 Napoli, Italy. ldandrea@unina.it
Istituto di Biostrutture e Bioimmagini, CNR, via Mezzocannone 16, 80134 Napoli, Italy
References: Hanahan, D., Folkman, J., Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis (1996) Cell, 86, pp. 353-36
Bergers, G., Benjamin, L.E., Tumorigenesis and the angiogenic switch (2003) Nat Rev Cancer, 3, pp. 401-410
Adams, R.H., Alitalo, K., Molecular regulation of angiogenesis and lymphangiogenesis (2007) Nat Rev Mol Cell Biol, 8, pp. 464-478
Carmeliet, P., Jain, R.K., Angiogenesis in cancer and other diseases (2000) Nature, 407, pp. 249-257
Folkman, J., Angiogenesis in cancer, vascular, rheumatoid and other disease (1995) Nat Med, 1, pp. 27-31
Carmeliet, P., Angiogenesis in life, disease and medicine (2005) Nature, 438, pp. 932-936
Ferrara, N., Kerbel, R.S., Angiogenesis as a therapeutic target (2005) Nature, 438, pp. 967-974
Bouis, D., Kusumanto, Y., Meijer, C., Mulder, N.H., Hospers, G.A., A review on pro- and anti-angiogenic factors as targets of clinical intervention (2006) Pharmacol Res, 53, pp. 89-103
Rajkumar, T., Growth factoprs and growth factor receptors in cancer (2001) Current Science, 81, pp. 535-241
Heppeler, A., Froidevaux, S., Eberle, A.N., Maecke, H.R., Receptor targeting for tumor localisation and therapy with radiopeptides (2000) Curr Med Chem, 7, pp. 971-994
Okarvi, S.M., Peptide-based radiopharmaceuticals: Future tools for diagnostic imaging of cancers and other diseases (2004) Med Res Rev, 24, pp. 357-397
Ruegg, C., Hasmim, M., Lejeune, F.J., Alghisi, G.C., Antiangiogenic peptides and proteins: From experimental tools to clinical drugs (2006) Biochim Biophys Acta, 1765, pp. 155-177
D'Andrea, L.D., Del Gatto, A., Pedone, C., Benedetti, E., Peptide-based molecules in angiogenesis (2006) Chem Biol Drug Des, 67, pp. 115-126
Dings, R.P., Nesmelova, I., Griffioen, A.W., Mayo, K.H., Discovery and development of anti-angiogenic peptides: A structural link (2003) Angiogenesis, 6, pp. 83-91
Sulochana, K.N., Ge, R., Developing antiangiogenic peptide drugs for angiogenesis-related diseases (2007) Curr Pharm Des, 13, pp. 2074-2086
Bouma-ter Steege, J.C., Mayo, K.H., Griffioen, A.W., Angiostatic proteins and peptides (2001) Crit Rev Eukaryot Gene Expr, 11, pp. 319-334
Folkman, J., Merler, E., Abernathy, C., Williams, G., Isolation of a tumor factor responsible for angiogenesis (1971) J Exp Med, 133, pp. 275-288
Abraham, J.A., Whang, J.L., Tumolo, A., Mergia, A., Fiddes, J.C., Human basic fibroblast growth factor: Nucleotide sequence, genomic organization, and expression in mammalian cells (1986) Cold Spring Harb Symp Quant Biol, 51 (PART 1), pp. 657-668
Abraham, J.A., Mergia, A., Whang, J.L., Tumolo, A., Friedman, J., Hjerrild, K.A., Nucleotide sequence of a bovine clone encoding the angiogenic protein, basic fibroblast growth factor (1986) Science, 233, pp. 545-548
Powers, C.J., McLeskey, S.W., Wellstein, A., Fibroblast growth factors, their receptors and signaling (2000) Endocr Relat Cancer, 7, pp. 165-197
Ago, H., Kitagawa, Y., Fujishima, A., Matsuura, Y., Katsube, Y., Crystal structure of basic fibroblast growth factor at 1.6 A resolution (1991) J Biochem, 110, pp. 360-363
Eriksson, A.E., Cousens, L.S., Weaver, L.H., Matthews, B.W., Three-dimensional structure of human basic fibroblast growth factor (1991) Proc Natl Acad Sci USA, 88, pp. 3441-3445
Zhu, X., Komiya, H., Chirino, A., Faham, S., Fox, G.M., Arakawa, T., Three-dimensional structures of acidic and basic fibroblast growth factors (1991) Science, 251, pp. 90-93
Zhang, J.D., Cousens, L.S., Barr, P.J., Sprang, S.R., Three-dimensional structure of human basic fibroblast growth factor, a structural homolog of interleukin 1 beta (1991) Proc Natl Acad Sci USA, 88, pp. 3446-3450
Reuss, B., von Bohlen, Halbach, O., Fibroblast growth factors and their receptors in the central nervous system (2003) Cell Tissue Res, 313, pp. 139-157
Ornitz DM, Itoh N. Fibroblast growth factors. Genome Biol 2001
2: reviews3005.1-3005.12Klagsbrun, M., Baird, A., A dual receptor system is required for basic fibroblast growth factor activity (1991) Cell, 67, pp. 229-231
Saksela, O., Moscatelli, D., Sommer, A., Rifkin, D.B., Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation (1988) J Cell Biol, 107, pp. 743-751
Turnbull, J.E., Gallagher, J.T., Heparan sulphate: Functional role as a modulator of fibroblast growth factor activity (1993) Biochem Soc Trans, 21, pp. 477-482
David, G., Integral membrane heparan sulfate proteoglycans (1993) Faseb J, 7, pp. 1023-1030
Ornitz, D.M., Leder, P., Ligand specificity and heparin dependence of fibroblast growth factor receptors 1 and 3 (1992) J Biol Chem, 267, pp. 16305-16311
Mansukhani, A., Dell'Era, P., Moscatelli, D., Kornbluth, S., Hanafusa, H., Basilico, C., Characterization of the murine BEK fibroblast growth factor (FGF) receptor: Activation by three members of the FGF family and requirement for heparin (1992) Proc Natl Acad Sci USA, 89, pp. 3305-3309
Yayon, A., Klagsbrun, M., Esko, J.D., Leder, P., Ornitz, D.M., Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor (1991) Cell, 64, pp. 841-848
Rapraeger, A.C., Krufka, A., Olwin, B.B., Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation (1991) Science, 252, pp. 1705-1708
Chaffer, C.L., Dopheide, B., Savagner, P., Thompson, E.W., Williams, E.D., Aberrant fibroblast growth factor receptor signaling in bladder and other cancers (2007) Differentiation, 75, pp. 831-842
Lee, P.L., Johnson, D.E., Cousens, L.S., Fried, V.A., Williams, L.T., Purification and complementary DNA cloning of a receptor for basic fibroblast growth factor (1989) Science, 245, pp. 57-60
Reid, H.H., Wilks, A.F., Bernard, O., Two forms of the basic fibroblast growth factor receptor-like mRNA are expressed in the developing mouse brain (1990) Proc Natl Acad Sci USA, 87, pp. 1596-1600
Safran, A., Avivi, A., Orr-Urtereger, A., Neufeld, G., Lonai, P., Givol, D., The murine flg gene encodes a receptor for fibroblast growth factor (1990) Oncogene, 5, pp. 635-643
Dionne, C.A., Crumley, G., Bellot, F., Kaplow, J.M., Searfoss, G., Ruta, M., Cloning and expression of two distinct high-affinity receptors cross-reacting with acidic and basic fibroblast growth factors (1990) EMBO J, 9, pp. 2685-2692
Keegan, K., Johnson, D.E., Williams, L.T., Hayman, M.J., Isolation of an additional member of the fibroblast growth factor receptor family, FGFR-3 (1991) Proc Natl Acad Sci USA, 88, pp. 1095-1099
Partanen, J., Makela, T.P., Eerola, E., Korhonen, J., Hirvonen, H., Claesson-Welsh, L., FGFR-4, a novel acidic fibroblast growth factor receptor with a distinct expression pattern (1991) EMBO J, 10, pp. 1347-1354
Stark, K.L., McMahon, J.A., McMahon, A.P., FGFR-4, a new member of the fibroblast growth factor receptor family, expressed in the definitive endoderm and skeletal muscle lineages of the mouse (1991) Development, 113, pp. 641-651
Zhang, X., Ibrahimi, O.A., Olsen, S.K., Umemori, H., Mohammadi, M., Ornitz, D.M., Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family (2006) J Biol Chem, 281, pp. 15694-15700
Stauber, D.J., DiGabriele, A.D., Hendrickson, W.A., Structural interactions of fibroblast growth factor receptor with its ligands (2000) Proc Natl Acad Sci USA, 97, pp. 49-54
Venkataraman, G., Shriver, Z., Davis, J.C., Sasisekharan, R., Fibroblast growth factors 1 and 2 are distinct in oligomerization in the presence of heparin-like glycosaminoglycans (1999) Proc Natl Acad Sci USA, 96, pp. 1892-1897
Zhan, X., Plourde, C., Hu, X., Friesel, R., Maciag, T., Association of fibroblast growth factor receptor-1 with c-Src correlates with association between c-Src and cortactin (1994) J Biol Chem, 269, pp. 20221-20224
Cross, M.J., Claesson-Welsh, L., FGF and VEGF function in angiogenesis: Signalling pathways, biological responses and therapeutic inhibition (2001) Trends Pharmacol Sci, 22, pp. 201-207
Cross, M.J., Hodgkin, M.N., Roberts, S., Landgren, E., Wakelam, M.J., Claesson-Welsh, L., Tyrosine 766 in the fibroblast growth factor receptor 1 is required for FGF-stimulation of phospholipase C, phospholipase D, phospholipase A(2), phosphoinositide 3-kinase and cytoskeletal reorganisation in porcine aortic endothelial cells (2000) J Cell Sci, 113 (PART 4), pp. 643-651
Raffioni, S., Thomas, D., Foehr, E.D., Thompson, L.M., Bradshaw, R.A., Comparison of the intracellular signaling responses by three chimeric fibroblast growth factor receptors in PC12 cells (1999) Proc Natl Acad Sci USA, 96, pp. 7178-7183
Presta, M., Dell'Era, P., Mitola, S., Moroni, E., Ronca, R., Rusnati, M., Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis (2005) Cytokine Growth Factor Rev, 16, pp. 159-178
Rusnati, M., Presta, M., Fibroblast growth factors/fibroblast growth factor receptors as targets for the development of anti-angiogenesis strategies (2007) Curr Pharm Des, 13, pp. 2025-2044
Mignatti, P., Rifkin, D.B., Nonenzymatic interactions between proteinases and the cell surface: Novel roles in normal and malignant cell physiology (2000) Adv Cancer Res, 78, pp. 103-157
Stokes, C.L., Rupnick, M.A., Williams, S.K., Lauffenburger, D.A., Chemotaxis of human microvessel endothelial cells in response to acidic fibroblast growth factor (1990) Lab Invest, 63, pp. 657-668
Terranova, V.P., DiFlorio, R., Lyall, R.M., Hic, S., Friesel, R., Maciag, T., Human endothelial cells are chemotactic to endothelial cell growth factor and heparin (1985) J Cell Biol, 101, pp. 2330-2334
Mattila, M.M., Ruohola, J.K., Valve, E.M., Tasanen, M.J., Seppanen, J.A., Harkonen, P.L., FGF-8b increases angiogenic capacity and tumor growth of androgen-regulated S115 breast cancer cells (2001) Oncogene, 20, pp. 2791-2804
Klein, S., Giancotti, F.G., Presta, M., Albelda, S.M., Buck, C.A., Rifkin, D.B., Basic fibroblast growth factor modulates integrin expression in microvascular endothelial cells (1993) Mol Biol Cell, 4, pp. 973-982
Collo, G., Pepper, M.S., Endothelial cell integrin alpha5beta1 expression is modulated by cytokines and during migration in vitro (1999) J Cell Sci, 112 (PART 4), pp. 569-578
Sepp, N.T., Li, L.J., Lee, K.H., Brown, E.J., Caughman, S.W., Lawley, T.J., Basic fibroblast growth factor increases expression of the alpha v beta 3 integrin complex on human microvascular endothelial cells (1994) J Invest Dermatol, 103, pp. 295-299
Underwood, P.A., Bean, P.A., Gamble, J.R., Rate of endothelial expansion is controlled by cell:cEll adhesion (2002) Int J Biochem Cell Biol, 34, pp. 55-69
Zhou, L., Dosanjh, A., Chen, H., Karasek, M., Divergent effects of extracellular oxygen on the growth, morphology, and function of human skin microvascular endothelial cells (2000) J Cell Physiol, 182, pp. 134-140
Gualandris, A., Rusnati, M., Belleri, M., Nelli, E.E., Bastaki, M., Molinari-Tosatti, M.P., Basic fibroblast growth factor overexpression in endothelial cells: An autocrine mechanism for angiogenesis and angioproliferative diseases (1996) Cell Growth Differ, 7, pp. 147-160
Armstrong, E., Vainikka, S., Partanen, J., Korhonen, J., Alitalo, R., Expression of fibroblast growth factor receptors in human leukemia cells (1992) Cancer Res, 52, pp. 2004-2007
Allouche, M., Bayard, F., Clamens, S., Fillola, G., Sie, P., Amalric, F., Expression of basic fibroblast growth factor (bFGF) and FGF-receptors in human leukemic cells (1995) Leukemia, 9, pp. 77-86
Katoh, O., Hattori, Y., Sato, T., Kimura, A., Kuramoto, A., Sugimura, T., Expression of the heparin-binding growth factor receptor genes in human megakaryocytic leukemia cells (1992) Biochem Biophys Res Commun, 183, pp. 83-92
Liuzzo, J.P., Moscatelli, D., Human leukemia cell lines bind basic fibroblast growth factor (FGF) on FGF receptors and heparan sulfates: Downmodulation of FGF receptors by phorbol ester (1996) Blood, 87, pp. 245-255
Basilico, C., Moscatelli, D., The FGF family of growth factors and oncogenes (1992) Adv Cancer Res, 59, pp. 115-165
Hagedorn, M., Bikfalvi, A., Target molecules for anti-angiogenic therapy: From basic research to clinical trials (2000) Crit Rev Oncol Hematol, 34, pp. 89-110
Tille, J.C., Wood, J., Mandriota, S.J., Schnell, C., Ferrari, S., Mestan, J., Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro (2001) J Pharmacol Exp Ther, 299, pp. 1073-1085
Seghezzi, G., Patel, S., Ren, C.J., Gualandris, A., Pintucci, G., Robbins, E.S., Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: An autocrine mechanism contributing to angiogenesis (1998) J Cell Biol, 141, pp. 1659-1673
Lindahl, U., Lidholt, K., Spillmann, D., Kjellen, L., More to "heparin" than anticoagulation (1994) Thromb Res, 75, pp. 1-32
Iozzo, R.V., San Antonio, J.D., Heparan sulfate proteoglycans: Heavy hitters in the angiogenesis arena (2001) J Clin Invest, 108, pp. 349-355
Ribatti, D., Leali, D., Vacca, A., Giuliani, R., Gualandris, A., Roncali, L., In vivo angiogenic activity of urokinase: Role of endogenous fibroblast growth factor-2 (1999) J Cell Sci, 112 (PART 23), pp. 4213-4221
Presta, M., Maier, J.A., Rusnati, M., Ragnotti, G., Basic fibroblast growth factor is released from endothelial extracellular matrix in a biologically active form (1989) J Cell Physiol, 140, pp. 68-74
Simons, M., Horowitz, A., Syndecan-4-mediated signalling (2001) Cell Signal, 13, pp. 855-862
Rusnati, M., Urbinati, C., Presta, M., Internalization of basic fibroblast growth factor (bFGF) in cultured endothelial cells: Role of the low affinity heparin-like bFGF receptors (1993) J Cell Physiol, 154, pp. 152-161
Hsia, E., Richardson, T.P., Nugent, M.A., Nuclear localization of basic fibroblast growth factor is mediated by heparan sulfate proteoglycans through protein kinase C signaling (2003) J Cell Biochem, 88, pp. 1214-1225
Gajdusek, C.M., Carbon, S., Injury-induced release of basic fibroblast growth factor from bovine aortic endothelium (1989) J Cell Physiol, 139, pp. 570-579
Gloe, T., Sohn, H.Y., Meininger, G.A., Pohl, U., Shear stress-induced release of basic fibroblast growth factor from endothelial cells is mediated by matrix interaction via integrin alpha(v)beta3 (2002) J Biol Chem, 277, pp. 23453-23458
Hartnett, M.E., Garcia, C.M., D'Amore, P.A., Release of bFGF, an endothelial cell survival factor, by osmotic shock (1999) Invest Ophthalmol Vis Sci, 40, pp. 2945-2951
Pugh, C.W., Oxygen sensing in cancer (2003) Ann Med, 35, pp. 380-390
Kuwabara, K., Ogawa, S., Matsumoto, M., Koga, S., Clauss, M., Pinsky, D.J., Hypoxia-mediated induction of acidic/basic fibroblast growth factor and platelet-derived growth factor in mononuclear phagocytes stimulates growth of hypoxic endothelial cells (1995) Proc Natl Acad Sci USA, 92, pp. 4606-4610
Li, J., Shworak, N.W., Simons, M., Increased responsiveness of hypoxic endothelial cells to FGF2 is mediated by HIF-1alpha-dependent regulation of enzymes involved in synthesis of heparan sulfate FGF2-binding sites (2002) J Cell Sci, 115, pp. 1951-1959
Ornitz, D.F., heparan sulfate and FGFRs: Complex interactions essential for development (2000) Bioessays, 22, pp. 108-112
Plotnikov, A.N., Hubbard, S.R., Schlessinger, J., Mohammadi, M., Crystal structures of two FGF-FGFR complexes reveal the determinants of ligand-receptor specificity (2000) Cell, 101, pp. 413-424
Moy, F.J., Seddon, A.P., Bohlen, P., Powers, R., High-resolution solution structure of basic fibroblast growth factor determined by multidimensional heteronuclear magnetic resonance spectroscopy (1996) Biochemistry, 35, pp. 13552-13561
Li, L.Y., Safran, M., Aviezer, D., Bohlen, P., Seddon, A.P., Yayon, A., Diminished heparin binding of a basic fibroblast growth factor mutant is associated with reduced receptor binding, mitogenesis, plasminogen activator induction, and in vitro angiogenesis (1994) Biochemistry, 33, pp. 10999-11007
Blaber, M., DiSalvo, J., Thomas, K.A., X-ray crystal structure of human acidic fibroblast growth factor (1996) Biochemistry, 35, pp. 2086-2094
Faham, S., Hileman, R.E., Fromm, J.R., Linhardt, R.J., Rees, D.C., Heparin structure and interactions with basic fibroblast growth factor (1996) Science, 271, pp. 1116-1120
DiGabriele, A.D., Lax, I., Chen, D.I., Svahn, C.M., Jaye, M., Schlessinger, J., Structure of a heparin-linked biologically active dimer of fibroblast growth factor (1998) Nature, 393, pp. 812-817
Plotnikov, A.N., Schlessinger, J., Hubbard, S.R., Mohammadi, M., Structural basis for FGF receptor dimerization and activation (1999) Cell, 98, pp. 641-650
Ornitz, D.M., Yayon, A., Flanagan, J.G., Svahn, C.M., Levi, E., Leder, P., Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells (1992) Mol Cell Biol, 12, pp. 240-247
Sudhalter, J., Folkman, J., Svahn, C.M., Bergendal, K., D'Amore, P.A., Importance of size, sulfation, and anticoagulant activity in the potentiation of acidic fibroblast growth factor by heparin (1989) J Biol Chem, 264, pp. 6892-6897
Schlessinger, J., Plotnikov, A.N., Ibrahimi, O.A., Eliseenkova, A.V., Yeh, B.K., Yayon, A., Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization (2000) Mol Cell, 6, pp. 743-750
Pellegrini, L., Burke, D.F., von Delft, F., Mulloy, B., Blundell, T.L., Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin (2000) Nature, 407, pp. 1029-1034
Kan, M., Wang, F., Xu, J., Crabb, J.W., Hou, J., McKeehan, W.L., An essential heparin-binding domain in the fibroblast growth factor receptor kinase (1993) Science, 259, pp. 1918-1921
Schubert, D., Ling, N., Baird, A., Multiple influences of a heparin-binding growth factor on neuronal development (1987) J Cell Biol, 104, pp. 635-643
Baird, A., Schubert, D., Ling, N., Guillemin, R., Receptor- and heparin-binding domains of basic fibroblast growth factor (1988) Proc Natl Acad Sci USA, 85, pp. 2324-2328
Ray, J., Baird, A., Gage, F.H., A 10-amino acid sequence of fibroblast growth factor 2 is sufficient for its mitogenic activity on neural progenitor cells (1997) Proc Natl Acad Sci USA, 94, pp. 7047-7052
Williams, E.J., Williams, G., Howell, F.V., Skaper, S.D., Walsh, F.S., Doherty, P., Identification of an N-cadherin motif that can interact with the fibroblast growth factor receptor and is required for axonal growth (2001) J Biol Chem, 276, pp. 43879-43886
Yayon, A., Aviezer, D., Safran, M., Gross, J.L., Heldman, Y., Cabilly, S., Isolation of peptides that inhibit binding of basic fibroblast growth factor to its receptor from a random phage-epitope library (1993) Proc Natl Acad Sci USA, 90, pp. 10643-10647
Terada, T., Mizobata, M., Kawakami, S., Yabe, Y., Yamashita, F., Hashida, M., Basic fibroblast growth factor-binding peptide as a novel targeting ligand of drug carrier to tumor cells (2006) J Drug Target, 14, pp. 536-545
Maruta, F., Parker, A.L., Fisher, K.D., Hallissey, M.T., Ismail, T., Rowlands, D.C., Identification of FGF receptor-binding peptides for cancer gene therapy (2002) Cancer Gene Ther, 9, pp. 543-552
Cosic, I., Drummond, A.E., Underwood, J.R., Hearn, M.T., In vitro inhibition of the actions of basic FGF by a novel 16 amino acid peptide (1994) Mol Cell Biochem, 130, pp. 1-9
McConnell, S.J., Thon, V.J., Spinella, D.G., Isolation of fibroblast growth factor receptor binding sequences using evolved phage display libraries (1999) Comb Chem High Throughput Screen, 2, pp. 155-163
Fan, H., Duan, Y., Zhou, H., Li, W., Li, F., Guo, L., Selection of peptide ligands binding to fibroblast growth factor receptor 1 (2002) IUBMB Life, 54, pp. 67-72
Oyama Jr., S., Miranda, M.T., Toma, I.N., Viviani, W., Gambarini, A.G., Mitogenic activity of peptides related to the sequence of human fibroblast growth factor-1 (1996) Biochem Mol Biol Int, 39, pp. 1237-1244
Kiyota, S., Franzoni, L., Nicastro, G., Benedetti, A., Oyama Jr., S., Viviani, W., Introduction of a chemical constraint in a short peptide derived from human acidic fibroblast growth factor elicits mitogenic structural determinants (2003) J Med Chem, 46, pp. 2325-2333
Tzeng, S.F., Deibler, G.E., DeVries, G.H., Myelin basic protein and myelin basic protein peptides induce the proliferation of Schwann cells via ganglioside GM1 and the FGF receptor (1999) Neurochem Res, 24, pp. 255-260
Li, S., Christensen, C., Kiselyov, V.V., Kohler, L.B., Bock, E., Berezin, V., Fibroblast growth factor-derived peptides: Functional agonists of the fibroblast growth factor receptor (2008) J Neurochem, 104, pp. 667-682
Anderson, A.A., Kendal, C.E., Garcia-Maya, M., Kenny, A.V., Morris-Triggs, S.A., Wu, T., A peptide from the first fibronectin domain of NCAM acts as an inverse agonist and stimulates FGF receptor activation, neurite outgrowth and survival (2005) J Neurochem, 95, pp. 570-583
Ballinger, M.D., Shyamala, V., Forrest, L.D., Deuter-Reinhard, M., Doyle, L.V., Wang, J.X., Semirational design of a potent, artificial agonist of fibroblast growth factor receptors (1999) Nat Biotechnol, 17, pp. 1199-1204
Kiselyov, V.V., Skladchikova, G., Hinsby, A.M., Jensen, P.H., Kulahin, N., Soroka, V., Structural basis for a direct interaction between FGFR1 and NCAM and evidence for a regulatory role of ATP (2003) Structure, 11, pp. 691-701
Neiiendam, J.L., Kohler, L.B., Christensen, C., Li, S., Pedersen, M.V., Ditlevsen, D.K., An NCAM-derived FGF-receptor agonist, the FGL-peptide, induces neurite outgrowth and neuronal survival in primary rat neurons (2004) J Neurochem, 91, pp. 920-935
Lin, X., Takahashi, K., Campion, S.L., Liu, Y., Gustavsen, G.G., Pena, L.A., Synthetic peptide F2A4-K-NS mimics fibroblast growth factor-2 in vitro and is angiogenic in vivo (2006) Int J Mol Med, 17, pp. 833-839
Lin, X., Pena, L.A., Zamora, P.O., Campion, S.L., Takahashi, K., Augmentation of demineralized bone matrix (DBM) mineralization by a synthetic growth factor mimetic (2006) J Orthop Res, 24, pp. 2051-2058
Ross, R., Glomset, J., Kariya, B., Harker, L., A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro (1974) Proc Natl Acad Sci USA, 71, pp. 1207-1210
Kazlauskas, A., Receptor tyrosine kinases and their targets (1994) Curr Opin Genet Dev, 4, pp. 5-14
Fredriksson, L., Li, H., Eriksson, U., The PDGF family: Four gene products form five dimeric isoforms (2004) Cytokine Growth Factor Rev, 15, pp. 197-204
Heldin, C.H., Westermark, B., Mechanism of action and in vivo role of platelet-derived growth factor (1999) Physiol Rev, 79, pp. 1283-1316
Fantl, W.J., Johnson, D.E., Williams, L.T., Signalling by receptor tyrosine kinases (1993) Annu Rev Biochem, 62, pp. 453-481
Matsui, T., Heidaran, M., Miki, T., Popescu, N., La Rochelle, W., Kraus, M., Isolation of a novel receptor cDNA establishes the existence of two PDGF receptor genes (1989) Science, 243, pp. 800-804
Andrae, J., Gallini, R., Betsholtz, C., Role of platelet-derived growth factors in physiology and medicine (2008) Genes Dev, 22, pp. 1276-1312
Heldin, C.H., Eriksson, U., Ostman, A., New members of the platelet-derived growth factor family of mitogens (2002) Arch Biochem Biophys, 398, pp. 284-290
Alvarez, R.H., Kantarjian, H.M., Cortes, J.E., Biology of platelet-derived growth factor and its involvement in disease (2006) Mayo Clin Proc, 81, pp. 1241-1257
Sundberg, C., Branting, M., Gerdin, B., Rubin, K., Tumor cell and connective tissue cell interactions in human colorectal adenocarcinoma. Transfer of platelet-derived growth factor-AB/BB to stromal cells (1997) Am J Pathol, 151, pp. 479-492
Yi, E.S., Lee, H., Yin, S., Piguet, P., Sarosi, I., Kaufmann, S., Platelet-derived growth factor causes pulmonary cell proliferation and collagen deposition in vivo (1996) Am J Pathol, 149, pp. 539-548
Rutherford, C., Martin, W., Carrier, M., Anggard, E.E., Ferns, G.A., Endogenously elicited antibodies to platelet derived growth factor- BB and platelet cytosolic protein inhibit aortic lesion development in the cholesterol-fed rabbit (1997) Int J Exp Pathol, 78, pp. 21-32
Abboud, H.E., Role of platelet-derived growth factor in renal injury (1995) Annu Rev Physiol, 57, pp. 297-309
Gesualdo, L., Di Paolo, S., Milani, S., Pinzani, M., Grappone, C., Ranieri, E., Expression of platelet-derived growth factor receptors in normal and diseased human kidney. An immunohistochemistry and in situ hybridization study (1994) J Clin Invest, 94, pp. 50-58
Gesualdo, L., Pinzani, M., Floriano, J.J., Hassan, M.O., Nagy, N.U., Schena, F.P., Platelet-derived growth factor expression in mesangial proliferative glomerulonephritis (1991) Lab Invest, 65, pp. 160-167
Yamamoto, M., Toya, Y., Jensen, R.A., Ishikawa, Y., Caveolin is an inhibitor of platelet-derived growth factor receptor signaling (1999) Exp Cell Res, 247, pp. 380-388
Engstrom, U., Engstrom, A., Ernlund, A., Westermark, B., Heldin, C.H., Identification of a peptide antagonist for platelet-derived growth factor (1992) J Biol Chem, 267, pp. 16581-16587
Brennand, D.M., Dennehy, U., Ellis, V., Scully, M.F., Tripathi, P., Kakkar, V.V., Identification of a cyclic peptide inhibitor of platelet-derived growth factor-BB receptor-binding and mitogen-induced DNA synthesis in human fibroblasts (1997) FEBS Lett, 413, pp. 70-74
Brennand, D.M., Scully, M.F., Kakkar, V.V., Patel, G., A cyclic peptide analogue of loop III of PDGF-BB causes apoptosis in human fibroblasts (1997) FEBS Lett, 419, pp. 166-170
Chiara, F., Bishayee, S., Heldin, C.H., Demoulin, J.B., Autoinhibition of the platelet-derived growth factor beta-receptor tyrosine kinase by its C-terminal tail (2004) J Biol Chem, 279, pp. 19732-19738
Nagy, J.A., Dvorak, A.M., Dvorak, H.F., VEGF-A and the Induction of Pathological Angiogenesis. Annu Rev (2007) Pathol, 2, pp. 251-275
Park, J.E., Keller, G.A., Ferrara, N., The vascular endothelial growth factor (VEGF) isoforms: Differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF (1993) Mol Biol Cell, 4, pp. 1317-1326
Roth, D., Piekarek, M., Paulsson, M., Christ, H., Bloch, W., Krieg, T., Plasmin modulates vascular endothelial growth factor-Amediated angiogenesis during wound repair (2006) Am J Pathol, 168, pp. 670-684
Woolard, J., Wang, W.Y., Bevan, H.S., Qiu, Y., Morbidelli, L., Pritchard-Jones, R.O., VEGF165b, an inhibitory vascular endothelial growth factor splice variant: Mechanism of action, in vivo effect on angiogenesis and endogenous protein expression (2004) Cancer Res, 64, pp. 7822-7835
Maglione, D., Guerriero, V., Viglietto, G., Delli-Bovi, P., Persico, M.G., Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor (1991) Proc Natl Acad Sci USA, 88, pp. 9267-9271
Luttun, A., Tjwa, M., Carmeliet, P., Placental growth factor (PlGF) and its receptor Flt-1 (VEGFR-1): Novel therapeutic targets for angiogenic disorders (2002) Ann N Y Acad Sci, 979, pp. 80-93
Fischer, C., Jonckx, B., Mazzone, M., Zacchigna, S., Loges, S., Pattarini, L., Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels (2007) Cell, 131, pp. 463-475
Roy, H., Bhardwaj, S., Yla-Herttuala, S., Biology of vascular endothelial growth factors (2006) FEBS Lett, 580, pp. 2879-2887
Iyer, S., Acharya, K.R., Role of placenta growth factor in cardiovascular health (2002) Trends Cardiovasc Med, 12, pp. 128-134
Carmeliet, P., Moons, L., Luttun, A., Vincenti, V., Compernolle, V., De Mol, M., Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions (2001) Nat Med, 7, pp. 575-583
Hauser, S., Weich, H.A., A heparin-binding form of placenta growth factor (PlGF-2) is expressed in human umbilical vein endothelial cells and in placenta (1993) Growth Factors, 9, pp. 259-268
Ferrara, N., Gerber, H.P., LeCouter, J., The biology of VEGF and its receptors (2003) Nat Med, 9, pp. 669-676
Ferrara N. VEGF: An update on biological and therapeutic aspects. Curr Opin Biotechnol 2000
11: 617-24Ferrara, N., Davis-Smyth, T., The biology of vascular endothelial growth factor (1997) Endocr Rev, 18, pp. 4-25
Cross, M.J., Dixelius, J., Matsumoto, T., Claesson-Welsh, L., VEGF-receptor signal transduction (2003) Trends Biochem Sci, 28, pp. 488-494
Veikkola, T., Karkkainen, M., Claesson-Welsh, L., Alitalo, K., Regulation of angiogenesis via vascular endothelial growth factor receptors (2000) Cancer Res, 60, pp. 203-212
Hicklin, D.J., Ellis, L.M., Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis (2005) J Clin Oncol, 23, pp. 1011-1027
Hiratsuka, S., Minowa, O., Kuno, J., Noda, T., Shibuya, M., Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice (1998) Proc Natl Acad Sci USA, 95, pp. 9349-9354
Hattori, K., Heissig, B., Wu, Y., Dias, S., Tejada, R., Ferris, B., Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment (2002) Nat Med, 8, pp. 841-849
Autiero, M., Waltenberger, J., Communi, D., Kranz, A., Moons, L., Lambrechts, D., Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1 (2003) Nat Med, 9, pp. 936-943
Kendall, R.L., Thomas, K.A., Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor (1993) Proc Natl Acad Sci USA, 90, pp. 10705-10709
Maynard, S.E., Min, J.Y., Merchan, J., Lim, K.H., Li, J., Mondal, S., Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia (2003) J Clin Invest, 111, pp. 649-658
Oliver, G., Alitalo, K., The lymphatic vasculature: Recent progress and paradigms (2005) Annu Rev Cell Dev Biol, 21, pp. 457-483
Alitalo, K., Tammela, T., Petrova, T.V., Lymphangiogenesis in development and human disease (2005) Nature, 438, pp. 946-953
Achen, M.G., Williams, R.A., Minekus, M.P., Thornton, G.E., Stenvers, K., Rogers, P.A., Localization of vascular endothelial growth factor D in malignant melanoma suggests a role in tumour angiogenesis (2001) J Pathol, 193, pp. 147-154
Valtola, R., Salven, P., Heikkila, P., Taipale, J., Joensuu, H., Rehn, M., VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer (1999) Am J Pathol, 154, pp. 1381-1390
Pellet-Many, C., Frankel, P., Jia, H., Zachary, I., Neuropilins: Structure, function and role in disease (2008) Biochem J, 411, pp. 211-226
Geretti, E., Shimizu, A., Klagsbrun, M., Neuropilin structure governs VEGF and semaphorin binding and regulates angiogenesis (2008) Angiogenesis, 11, pp. 31-39
Muller, Y.A., Christinger, H.W., Keyt, B.A., de Vos, A.M., The crystal structure of vascular endothelial growth factor (VEGF) refined to 1.93 A resolution: Multiple copy flexibility and receptor binding (1997) Structure, 5, pp. 1325-1338
Muller, Y.A., Li, B., Christinger, H.W., Wells, J.A., Cunningham, B.C., de Vos, A.M., Vascular endothelial growth factor: Crystal structure and functional mapping of the kinase domain receptor binding site (1997) Proc Natl Acad Sci USA, 94, pp. 7192-7197
Pan, B., Li, B., Russell, S.J., Tom, J.Y., Cochran, A.G., Fairbrother, W.J., Solution structure of a phage-derived peptide antagonist in complex with vascular endothelial growth factor (2002) J Mol Biol, 316, pp. 769-787
Wiesmann, C., Christinger, H.W., Cochran, A.G., Cunningham, B.C., Fairbrother, W.J., Keenan, C.J., Crystal structure of the complex between VEGF and a receptor-blocking peptide (1998) Biochemistry, 37, pp. 17765-17772
Muller, Y.A., Chen, Y., Christinger, H.W., Li, B., Cunningham, B.C., Lowman, H.B., VEGF and the Fab fragment of a humanized neutralizing antibody: Crystal structure of the complex at 2.4 A resolution and mutational analysis of the interface (1998) Structure, 6, pp. 1153-1167
Starovasnik, M.A., Christinger, H.W., Wiesmann, C., Champe, M.A., de Vos, A.M., Skelton, N.J., Solution structure of the VEGF-binding domain of Flt-1: Comparison of its free and bound states (1999) J Mol Biol, 293, pp. 531-544
Wiesmann, C., Fuh, G., Christinger, H.W., Eigenbrot, C., Wells, J.A., de Vos, A.M., Crystal structure at 1.7 A resolution of VEGF in complex with domain 2 of the Flt-1 receptor (1997) Cell, 91, pp. 695-704
Christinger, H.W., Fuh, G., de Vos, A.M., Wiesmann, C., The crystal structure of placental growth factor in complex with domain 2 of vascular endothelial growth factor receptor-1 (2004) J Biol Chem, 279, pp. 10382-10388
McTigue, M.A., Wickersham, J.A., Pinko, C., Showalter, R.E., Parast, C.V., Tempczyk-Russell, A., Crystal structure of the kinase domain of human vascular endothelial growth factor receptor 2: A key enzyme in angiogenesis (1999) Structure, 7, pp. 319-330
Ruch, C., Skiniotis, G., Steinmetz, M.O., Walz, T., Ballmer-Hofer, K., Structure of a VEGF-VEGF receptor complex determined by electron microscopy (2007) Nat Struct Mol Biol, 14, pp. 249-250
Keyt, B.A., Nguyen, H.V., Berleau, L.T., Duarte, C.M., Park, J., Chen, H., Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis (1996) J Biol Chem, 271, pp. 5638-5646
Lee, C.C., Kreusch, A., McMullan, D., Ng, K., Spraggon, G., Crystal structure of the human neuropilin-1 b1 domain (2003) Structure, 11, pp. 99-108
Appleton, B.A., Wu, P., Maloney, J., Yin, J., Liang, W.C., Stawicki, S., Structural studies of neuropilin/antibody complexes provide insights into semaphorin and VEGF binding (2007) Embo J, 26, pp. 4902-4912
Vander Kooi, C.W., Jusino, M.A., Perman, B., Neau, D.B., Bellamy, H.D., Leahy, D.J., Structural basis for ligand and heparin binding to neuropilin B domains (2007) Proc Natl Acad Sci USA, 104, pp. 6152-6157
Zachary, I., Vascular endothelial growth factor and anti-angiogenic peptides as therapeutic and investigational molecules (2003) IDrugs, 6, pp. 224-231
Ferrara, N., Hillan, K.J., Gerber, H.P., Novotny, W., Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer (2004) Nat Rev Drug Discov, 3, pp. 391-400
Underiner, T.L., Ruggeri, B., Gingrich, D.E., Development of vascular endothelial growth factor receptor (VEGFR) kinase inhibitors as anti-angiogenic agents in cancer therapy (2004) Curr Med Chem, 11, pp. 731-745
Sun, J., Blaskovich, M.A., Jain, R.K., Delarue, F., Paris, D., Brem, S., Blocking angiogenesis and tumorigenesis with GFA-116, a synthetic molecule that inhibits binding of vascular endothelial growth factor to its receptor (2004) Cancer Res, 64, pp. 3586-3592
Holash, J., Davis, S., Papadopoulos, N., Croll, S.D., Ho, L., Russell, M., VEGF-Trap: A VEGF blocker with potent antitumor effects (2002) Proc Natl Acad Sci USA, 99, pp. 11393-11398
Niethammer, A.G., Xiang, R., Becker, J.C., Wodrich, H., Pertl, U., Karsten, G., A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth (2002) Nat Med, 8, pp. 1369-1375
Takei, Y., Kadomatsu, K., Yuzawa, Y., Matsuo, S., Muramatsu, T., A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics (2004) Cancer Res, 64, pp. 3365-3370
Quesada, A.R., Munoz-Chapuli, R., Medina, M.A., Anti-angiogenic drugs: From bench to clinical trials (2006) Med Res Rev, 26, pp. 483-530
Jia, H., Jezequel, S., Lohr, M., Shaikh, S., Davis, D., Soker, S., Peptides encoded by exon 6 of VEGF inhibit endothelial cell biological responses and angiogenesis induced by VEGF (2001) Biochem Biophys Res Commun, 283, pp. 164-173
Bainbridge, J.W., Jia, H., Bagherzadeh, A., Selwood, D., Ali, R.R., Zachary, I., A peptide encoded by exon 6 of VEGF (EG3306) inhibits VEGF-induced angiogenesis in vitro and ischaemic retinal neovascularisation in vivo (2003) Biochem Biophys Res Commun, 302, pp. 793-799
Cheng, L., Jia, H., Lohr, M., Bagherzadeh, A., Holmes, D.I., Selwood, D., Anti-chemorepulsive effects of vascular endothelial growth factor and placental growth factor-2 in dorsal root ganglion neurons are mediated via neuropilin-1 and cyclooxygenase-derived prostanoid production (2004) J Biol Chem, 279, pp. 30654-30661
Giordano, R.J., Cardo-Vila, M., Lahdenranta, J., Pasqualini, R., Arap, W., Biopanning and rapid analysis of selective interactive ligands (2001) Nat Med, 7, pp. 1249-1253
Giordano, R.J., Anobom, C.D., Cardo-Vila, M., Kalil, J., Valente, A.P., Pasqualini, R., Structural basis for the interaction of a vascular endothelial growth factor mimic peptide motif and its corresponding receptors (2005) Chem Biol, 12, pp. 1075-1083
Binetruy-Tournaire, R., Demangel, C., Malavaud, B., Vassy, R., Rouyre, S., Kraemer, M., Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis (2000) Embo J, 19, pp. 1525-1533
Perret, G.Y., Starzec, A., Hauet, N., Vergote, J., Le Pecheur, M., Vassy, R., In vitro evaluation and biodistribution of a 99mTc-labeled anti-VEGF peptide targeting neuropilin-1 (2004) Nucl Med Biol, 31, pp. 575-581
Starzec, A., Vassy, R., Martin, A., Lecouvey, M., Di Benedetto, M., Crepin, M., Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1 (2006) Life Sci, 79, pp. 2370-2381
Starzec, A., Ladam, P., Vassy, R., Badache, S., Bouchemal, N., Navaza, A., Structure-function analysis of the antiangiogenic ATWLPPR peptide inhibiting VEGF(165) binding to neuropilin-1 and molecular dynamics simulations of the ATWLPPR/neuropilin-1 complex (2007) Peptides, 28, pp. 2397-2402
Bae, D.G., Kim, T.D., Li, G., Yoon, W.H., Chae, C.B., Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis (2005) Clin Cancer Res, 11, pp. 2651-2661
von Wronski, M.A., Raju, N., Pillai, R., Bogdan, N.J., Marinelli, E.R., Nanjappan, P., Tuftsin binds neuropilin-1 through a sequence similar to that encoded by exon 8 of vascular endothelial growth factor (2006) J Biol Chem, 281, pp. 5702-5710
Qin, X., Wan, Y., Li, M., Xue, X., Wu, S., Zhang, C., Identification of a novel peptide ligand of human vascular endothelia growth factor receptor 3 for targeted tumour diagnosis and therapy (2007) J Biochem, 142, pp. 79-85
Shrivastava, A., von Wronski, M.A., Sato, A.K., Dransfield, D.T., Sexton, D., Bogdan, N., A distinct strategy to generate high-affinity peptide binders to receptor tyrosine kinases (2005) Protein Eng Des Sel, 18, pp. 417-424
Goncalves, V., Gautier, B., Coric, P., Bouaziz, S., Lenoir, C., Garbay, C., Rational design, structure, and biological evaluation of cyclic peptides mimicking the vascular endothelial growth factor (2007) J Med Chem, 50, pp. 5135-5146
Taylor, A.P., Goldenberg, D.M., Role of placenta growth factor in malignancy and evidence that an antagonistic PlGF/Flt-1 peptide inhibits the growth and metastasis of human breast cancer xenografts (2007) Mol Cancer Ther, 6, pp. 524-531
Udugamasooriya, D.G., Dineen, S.P., Brekken, R.A., Kodadek, T., A peptoid "antibody surrogate" that antagonizes VEGF receptor 2 activity (2008) J Am Chem Soc, 130, pp. 5744-5752
Albini, A., Soldi, R., Giunciuglio, D., Giraudo, E., Benelli, R., Primo, L., The angiogenesis induced by HIV-1 tat protein is mediated by the Flk-1/KDR receptor on vascular endothelial cells (1996) Nat Med, 2, pp. 1371-1375
D'Andrea, L.D., Iaccarino, G., Fattorusso, R., Sorriento, D., Carannante, C., Capasso, D., Targeting angiogenesis: Structural characterization and biological properties of a de novo engineered VEGF mimicking peptide (2005) Proc Natl Acad Sci USA, 102, pp. 14215-14220
Dudar, G.K., D'Andrea, L.D., Di Stasi, R., Pedone, C., Wallace, J.L., A Vascular Endothelial Growth Factor Mimetic Accelerates Gastric Ulcer Healing in an iNOS-Dependent Manner (2008) Am J Physiol, , Gastrointest Liver Physiol
Waslif, J., (2004) Angiogenesis Inhibitors and Stimulators:tHe Emergence of a New Market
Jacobs, J., Combating cardiovascular disease with angiogenic therapy (2007) Drug Discov Today, 12, pp. 1040-1045
Kerbel, R., Folkman, J., Clinical translation of angiogenesis inhibitors (2002) Nat Rev Cancer, 2, pp. 727-739
Featherstone, J., Griffiths, S., From the analyst's couch. Drugs that target angiogenesis (2002) Nat Rev Drug Discov, 1, pp. 413-414
Cristofanilli, M., Charnsangavej, C., Hortobagyi, G.N., Angiogenesis modulation in cancer research: Novel clinical approaches (2002) Nat Rev Drug Discov, 1, pp. 415-426
Ferrara, N., Alitalo, K., Clinical applications of angiogenic growth factors and their inhibitors (1999) Nat Med, 5, pp. 1359-1364
Choe, Y.S., Lee, K.H., Targeted in vivo imaging of angiogenesis: Present status and perspectives (2007) Curr Pharm Des, 13, pp. 17-31
Ferrara, N., Mass, R.D., Campa, C., Kim, R., Targeting VEGF-A to treat cancer and age-related macular degeneration (2007) Annu Rev Med, 58, pp. 491-504
Million, R.P., Therapeutic area crossroads:aNti-angiogenesis (2008) Nature Rev. Drug Discov, 7, pp. 115-116
Simons, M., Ware, J.A., Therapeutic angiogenesis in cardiovascular disease (2003) Nat Rev Drug Discov, 2, pp. 863-871
Weis, S.M., Cheresh, D.A., Pathophysiological consequences of VEGF-induced vascular permeability (2005) Nature, 437, pp. 497-504
Lee, C.G., Link, H., Baluk, P., Homer, R.J., Chapoval, S., Bhandari, V., Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung (2004) Nat Med, 10, pp. 1095-1103
Molin, D., Post, M.J., Therapeutic angiogenesis in the heart: Protect and serve (2007) Curr Opin Pharmacol, 7, pp. 158-163
Emanueli, C., Madeddu, P., Changing the logic of therapeutic angiogenesis for ischemic disease (2005) Trends Mol Med, 11, pp. 207-216
Hetian, L., Ping, A., Shumei, S., Xiaoying, L., Luowen, H., Jian, W., A novel peptide isolated from a phage display library inhibits tumor growth and metastasis by blocking the binding of vascular endothelial growth factor to its kinase domain receptor (2002) J Biol Chem, 277, pp. 43137-43142
Zilberberg, L., Shinkaruk, S., Lequin, O., Rousseau, B., Hagedorn, M., Costa, F., Structure and inhibitory effects on angiogenesis and tumor development of a new vascular endothelial growth inhibitor (2003) J Biol Chem, 278, pp. 35564-35573
El-Mousawi, M., Tchistiakova, L., Yurchenko, L., Pietrzynski, G., Moreno, M., Stanimirovic, D., A vascular endothelial growth factor high affinity receptor 1-specific peptide with antiangiogenic activity identified using a phage display peptide library (2003) J Biol Chem, 278, pp. 46681-46691
An, P., Lei, H., Zhang, J., Song, S., He, L., Jin, G., Suppression of tumor growth and metastasis by a VEGFR-1 antagonizing peptide identified from a phage display library (2004) Int J Cancer, 111, pp. 165-173
Peptides targeting angiogenesis related growth factor receptors
Bogdanovich S, Kim Y, Mizutani T, Yasuma R, Tudisco L, Cicatiello V, Bastos-carvalho A, Kerur N, Hirano Y, Baffi JZ, Tarallo V, Li S, Yasuma T, Arpitha P, Fowler BJ, Wright CB, Apicella I, Greco A, Brunetti A, Ruvo M, Sandomenico A, Nozaki M, Ijima R, Kaneko H, Ogura Y, Terasaki H, Ambati BK, Leusen JH, Langdon WY, Clark MR, Armour KL, Bruhns P, Verbeek JS, Gelfand BD, De Falco S, Ambati J * Human IgG1 antibodies suppress angiogenesis in a target-independent manner(557 views) Signal Transduct Target Ther (ISSN: 2059-3635print), 2016; 1: N/D-N/D. Impact Factor:0 ViewExport to BibTeXExport to EndNote
Santulli G, Cipolletta E, Sorriento D, Del Giudice C, Anastasio A, Monaco S, Maione AS, Condorelli G, Puca A, Trimarco B, Illario M, Iaccarino G * CaMK4 gene deletion induces hypertension(349 views) J Am Heart Assoc Journal Of The American Heart Association (ISSN: 2047-9980), 2012; 1(4): N/D-N/D. Impact Factor:2.882 ViewExport to BibTeXExport to EndNote
Ntziachristos V, Cuénod CA, Fournier L, Balvay D, Pradel C, Siauve N, Clement O, Jouannot E, Lucidarme O, Vecchio SD, Salvatore M, Law B, Tung C-H, Jain RK, Fukumura D, Munn LL, Brown EB, Schellenberger E, Montet X, Weissleder R, Clerck ND, Postnov A * Tumor Imaging(350 views) Textbook Of In Vivo Imaging In Vertebrates (ISSN: 9780-4700), 2007 Jul 16; 1: 277-309. Impact Factor:1.148 ViewExport to BibTeXExport to EndNote